Literature DB >> 11928769

Limited clinical utility of high-sensitivity plasma C-reactive protein assays.

Bruce Campbell1, Tony Badrick, Robert Flatman, David Kanowski.   

Abstract

Many recent studies have shown a relationship between plasma C-reactive protein (CRP) concentrations and risk of cardiovascular disease. However, the intra-individual variation in plasma CRP concentrations is large. Use of plasma CRP measurement in individual patients is likely to result in many being misclassified in their risk status. Use of repeated measurements is not a practical solution to this problem.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11928769     DOI： 10.1258/0004563021901757

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN： 0004-5632            Impact factor:   2.057


  9 in total

1.  C-reactive protein levels in patients on maintenance hemodialysis: reliability and reflection on the utility of single measurements.

Authors:  Caroline E Stigant; Ognjenka Djurdjev; Adeera Levin
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Discordances among different tools used to estimate cardiovascular risk in postmenopausal women.

Authors:  Pascal Pelletier; Annie Lapointe; Nathalie Laflamme; Marie-Eve Piché; Stanley John Weisnagel; André Nadeau; Simone Lemieux; Jean Bergeron
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

3.  Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?

Authors:  James P McCormack; G Michael Allan
Journal:  PLoS Med       Date:  2010-02-02       Impact factor: 11.069

4.  Anti-inflammatory nutrition as a pharmacological approach to treat obesity.

Authors:  Barry Sears; Camillo Ricordi
Journal:  J Obes       Date:  2010-09-30

5.  Disparate effects of atorvastatin compared with simvastatin on C-reactive protein concentrations in patients with type 2 diabetes.

Authors:  Thozhukat Sathyapalan; Stephen L Atkin; Eric S Kilpatrick
Journal:  Diabetes Care       Date:  2010-09       Impact factor: 19.112

6.  Prognostic utility of biochemical markers of cardiovascular risk: impact of biological variability.

Authors:  Kristine S Alexander; Steven C Kazmierczak; Caryn K Snyder; Jon A Oberdorf; David H Farrell
Journal:  Clin Chem Lab Med       Date:  2013-09       Impact factor: 3.694

7.  Long-term exposure to outdoor air pollution and risk factors for cardiovascular disease within a cohort of older men in Perth.

Authors:  Stephen Vander Hoorn; Kevin Murray; Lee Nedkoff; Graeme J Hankey; Leon Flicker; Bu B Yeap; Osvaldo P Almeida; Paul Norman; Bert Brunekreef; Mark Nieuwenhuijsen; Jane Heyworth
Journal:  PLoS One       Date:  2021-03-29       Impact factor: 3.240

8.  Time variability of C-reactive protein: implications for clinical risk stratification.

Authors:  Peter Bogaty; Gilles R Dagenais; Lawrence Joseph; Luce Boyer; Anne Leblanc; Patrick Bélisle; James M Brophy
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

9.  Serum High-Sensitivity C-Reactive Protein Levels and Response to 5 mg Tadalafil Once Daily in Patients With Erectile Dysfunction and Diabetes.

Authors:  Jung Woo Lee; Hyun Jun Park; Nam Cheol Park
Journal:  Korean J Urol       Date:  2013-12-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.